Rosenblum Mark J
SEC CIK 1329154 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DCOY | Decoy Therapeutics Inc. | CFO, EVP Fin | 11.4K | $50.8K | — | 11 | 2021-11-03 | 2026-08-31 |
Most active insiders at DCOY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Rosenblum Mark J | CFO, EVP Fin | $16.0K | — |
| 2 | HANISH ARNOLD C | Dir | $3,750 | $17.28 |
| 3 | Gauthier Patricia G. | Dir | — | — |
| 4 | Marschel Peter Klaus | Chief Business Off | — | — |
| 5 | Hibner Barbara Louise | CSO | — | — |
| 6 | Burleson Tess | Dir | — | — |
| 7 | McVicar William K. | Dir | — | — |
| 8 | Lammers Paul | Dir | — | — |
| 9 | Lieber Jonathan I | Dir | — | — |
| 10 | PIERCE FREDERICK II | CEO | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-02 17:48 | 2026-08-31 | DCOY | Decoy Therapeutics Inc. | Rosenblum Mark J | CFO | A - Grant | $0.00 | +9,682 | 11.4K | +576% | $0 | |
| 2025-11-20 | 2025-11-20 | DCOY | Decoy Therapeutics Inc. | Rosenblum Mark J | CFO, EVP Fin | P - Purchase | $0.8 | +20.0K | 20.2K | +11,299% | +$16.0K | |
| 2023-02-15 | 2023-02-13 | DCOY | Decoy Therapeutics Inc. | Rosenblum Mark J | CFO, EVP Fin | A - Grant | $0.00 | +6,432 | 21.9K | +42% | $0 | |
| 2023-01-05 | 2023-01-03 | DCOY | Decoy Therapeutics Inc. | Rosenblum Mark J | CFO, EVP Fin | A - Grant | $0.00 | +8,000 | 15.4K | +108% | $0 | |
| A | 2022-12-12 | 2022-11-03 | DCOY | Decoy Therapeutics Inc. | Rosenblum Mark J | CFO, EVP Fin | A - Grant | $1.73 | +1,488 | 7,419 | +25% | +$2,574 |
| A | 2022-11-08 | 2022-11-03 | DCOY | Decoy Therapeutics Inc. | Rosenblum Mark J | CFO, EVP Fin | A - Grant | $1.73 | +7,314 | 13.2K | +123% | +$12.7K |
| 2022-11-07 | 2022-11-03 | DCOY | Decoy Therapeutics Inc. | Rosenblum Mark J | CFO, EVP Fin | A - Grant | $1.73 | +7,314 | 155.6K | +5% | +$12.7K | |
| 2022-05-31 | 2022-05-31 | DCOY | Decoy Therapeutics Inc. | Rosenblum Mark J | CFO, EVP Fin | P - Purchase | $0.18 | +28.0K | 148.3K | +23% | +$5,040 | |
| 2022-05-05 | 2022-05-03 | DCOY | Decoy Therapeutics Inc. | Rosenblum Mark J | CFO, EVP Fin | A - Grant | $0.19 | +10.0K | 120.3K | +9% | +$1,900 | |
| 2022-03-09 | 2022-03-03 | DCOY | Decoy Therapeutics Inc. | Rosenblum Mark J | CFO, EVP Fin | P - Purchase | $0.39 | +76.2K | 110.3K | +224% | +$29.7K | |
| 2021-11-05 | 2021-11-03 | DCOY | Decoy Therapeutics Inc. | Rosenblum Mark J | CFO, EVP Fin | A - Grant | $0.72 | +7,787 | 34.1K | +30% | +$5,607 |
Purchase Sale Sale after option exercise All abbreviations